![](/images/graphics-bg.png)
Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis
المؤلفون المشاركون
Hamid, Ban Hadi
Ali, Ahmad Subayh Abd
Saghir, Halah Abd al-Ghani
المصدر
al-Kindy College Medical Journal
العدد
المجلد 14، العدد 1 (30 يونيو/حزيران 2018)، ص ص. 4-7، 4ص.
الناشر
تاريخ النشر
2018-06-30
دولة النشر
العراق
عدد الصفحات
4
التخصصات الرئيسية
الملخص EN
Background: Osteoporosis is a skeletal defect manifested by a reduction of bone strength as a result of reduced bone mass to the extent that there is a higher risk of fracture even on minor trauma.
Hysterectomy in a premenopausal woman is a well known cause of ovarian failure resulting in an increased risk of osteoporosis.
Objective : To clarify bisphosphonate's preventive effect on osteopenia and osteoporosis in premenopausal women after hysterectomy.
Type of the study: Cross –sectional study.
Method: 84 premenopausal females post hysterectomy aged between 40 – 50 years, were enrolled in this randomized controlled double blinded trail at Al Yarmouk teaching hospital and private clinic in Baghdad for a period of two years from Augest 2011 till July 2013.
Participants were assigned as: 1stgroup (study group 42 women): received risedronate treatment "over a period of one year" with calcium and vitamin D; and 2ndgroup (control group 42 women) were taken as a matched group for:"age, body mass index (BMI) and fracture history", received only calcium and vitamin D as a placebo.
Bone density had been assayed at the end of the year for all participants and evaluated for osteopenia and osteoporosis.
Results: Osteopenia and osteoporosis were significantly lower in the risedronate arm as compared to those not received the drug "14.3% & 11.9% versus 26.1% & 19% respectively".
Conclusion: The bone mineral density results were significantly better in those who received risedronate than those not received the drug.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Hamid, Ban Hadi& Ali, Ahmad Subayh Abd& Saghir, Halah Abd al-Ghani. 2018. Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. al-Kindy College Medical Journal،Vol. 14, no. 1, pp.4-7.
https://search.emarefa.net/detail/BIM-840155
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Hamid, Ban Hadi…[et al.]. Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. al-Kindy College Medical Journal Vol. 14, no. 1 (2018), pp.4-7.
https://search.emarefa.net/detail/BIM-840155
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Hamid, Ban Hadi& Ali, Ahmad Subayh Abd& Saghir, Halah Abd al-Ghani. Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. al-Kindy College Medical Journal. 2018. Vol. 14, no. 1, pp.4-7.
https://search.emarefa.net/detail/BIM-840155
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 6-7
رقم السجل
BIM-840155
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)